Total Payments
$14,868
2024 Payments
$2,896
Companies
43
Transactions
776
Medicare Patients
12,488
Medicare Billing
$910,345
Payment Breakdown by Category
Food & Beverage$14,792 (99.5%)
Education$57.15 (0.4%)
Consulting$18.62 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,792 | 771 | 99.5% |
| Education | $57.15 | 4 | 0.4% |
| Consulting Fee | $18.62 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,389 | 94 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,333 | 91 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,222 | 94 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,101 | 64 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $966.07 | 43 | $0 (2024) |
| Amgen Inc. | $890.01 | 49 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $836.09 | 53 | $0 (2024) |
| Medtronic, Inc. | $745.35 | 13 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $719.51 | 34 | $0 (2024) |
| Amarin Pharma Inc. | $565.20 | 23 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,896 | 121 | PFIZER INC. ($300.60) |
| 2023 | $2,826 | 140 | E.R. Squibb & Sons, L.L.C. ($308.85) |
| 2022 | $2,064 | 107 | Medtronic, Inc. ($287.85) |
| 2021 | $743.81 | 42 | Janssen Pharmaceuticals, Inc ($134.37) |
| 2020 | $733.51 | 37 | PFIZER INC. ($121.14) |
| 2019 | $2,412 | 119 | Amarin Pharma Inc. ($262.78) |
| 2018 | $1,876 | 113 | Novartis Pharmaceuticals Corporation ($252.12) |
| 2017 | $1,315 | 97 | Janssen Pharmaceuticals, Inc ($148.55) |
All Payment Transactions
776 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $38.30 | General |
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.28 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.57 | General |
| 12/02/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Not Applicable | ||||||
| 11/21/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $0.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2024 | Boston Scientific Corporation | RESONATE EL ICD VR (Device) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: RESONATE_CRM | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Obesity | ||||||
| 11/04/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Pacemakers | ||||||
| 10/30/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $124.03 | General |
| Category: Renal Denervation System | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Pacemakers | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Obesity | ||||||
| 10/21/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $25.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.54 | General |
| Category: Cardiovascular | ||||||
| 10/08/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Not Applicable | ||||||
| 10/07/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $146.80 | General |
| Category: Heart Failure | ||||||
| 09/27/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $27.01 | General |
| 09/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,986 | 3,874 | $808,243 | $200,019 |
| 2022 | 25 | 3,269 | 4,579 | $968,384 | $237,237 |
| 2021 | 29 | 3,509 | 4,765 | $1.0M | $277,530 |
| 2020 | 26 | 2,724 | 3,431 | $524,683 | $195,560 |
Total Patients
12,488
Total Services
16,649
Medicare Billing
$910,345
Procedure Codes
125
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 453 | 724 | $289,502 | $67,181 | 23.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 151 | 154 | $82,698 | $21,715 | 26.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 97 | 162 | $59,778 | $15,909 | 26.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 84 | 87 | $54,462 | $13,202 | 24.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 221 | 222 | $46,398 | $12,130 | 26.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 143 | 183 | $45,018 | $11,934 | 26.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 502 | 781 | $35,926 | $8,711 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $31,842 | $8,066 | 25.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 41 | 41 | $23,042 | $5,986 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 38 | 41 | $18,163 | $4,684 | 25.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 476 | 669 | $17,394 | $4,430 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 29 | $16,240 | $3,676 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 35 | 36 | $10,872 | $2,908 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 29 | $8,236 | $2,123 | 25.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 27 | 36 | $9,108 | $2,106 | 23.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $7,676 | $2,055 | 26.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 22 | 22 | $7,128 | $1,908 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 17 | 17 | $7,038 | $1,773 | 25.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 42 | 42 | $6,510 | $1,702 | 26.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 71 | 75 | $5,700 | $1,524 | 26.7% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 14 | 14 | $4,704 | $1,257 | 26.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 78 | 78 | $5,070 | $1,225 | 24.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 85 | 85 | $3,655 | $889.20 | 24.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 39 | 39 | $3,081 | $782.55 | 25.4% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 11 | 18 | $3,096 | $659.43 | 21.3% |
About Dr. Daniel Plotnick, MD
Dr. Daniel Plotnick, MD is a Cardiovascular Disease healthcare provider based in Towson, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356486039.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Plotnick, MD has received a total of $14,868 in payments from pharmaceutical and medical device companies, with $2,896 received in 2024. These payments were reported across 776 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($14,792).
As a Medicare-enrolled provider, Plotnick has provided services to 12,488 Medicare beneficiaries, totaling 16,649 services with total Medicare billing of $910,345. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Towson, MD
- Active Since 02/21/2007
- Last Updated 10/07/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356486039
Products in Payments
- ELIQUIS (Drug) $1,608
- XARELTO (Drug) $1,317
- ENTRESTO (Drug) $990.67
- Vascepa (Drug) $565.20
- Repatha (Biological) $548.62
- LifeVest (Device) $483.25
- JARDIANCE (Drug) $437.23
- PRALUENT (Drug) $430.48
- BRILINTA (Drug) $389.07
- VYNDAQEL (Drug) $366.80
- CAMZYOS (Drug) $354.51
- Corlanor (Drug) $341.39
- FARXIGA (Drug) $312.07
- MULTAQ (Drug) $289.03
- ONPATTRO (Drug) $261.31
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $250.97
- ONYX FRONTIER (Device) $245.14
- MYCARELINK (Device) $240.56
- Impella (Device) $220.48
- NEXLETOL (Drug) $220.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Towson
Dr. Jeremy Pollock, M.d, M.D
Cardiovascular Disease — Payments: $81,248
Cardiovascular Disease $81,248
Dr. Nilofar Islam, Md, MD
Cardiovascular Disease — Payments: $61,601
Cardiovascular Disease $61,601
Dr. Michael Drossner, M.d, M.D
Cardiovascular Disease — Payments: $20,792
Cardiovascular Disease $20,792
Ronald Schechter, M.d, M.D
Cardiovascular Disease — Payments: $12,075
Cardiovascular Disease $12,075
Sonia Baker, Md, MD
Cardiovascular Disease — Payments: $10,179
Cardiovascular Disease $10,179
Dr. Michael Pressel, M.d, M.D
Cardiovascular Disease — Payments: $9,201
Cardiovascular Disease $9,201